Guangzhou Doublle Bioproduct Co Announces Clinical Update and Partner Search for Adenolysin for Head and Neck Cancer
Guangzhou Doublle Bioproduct gives a clinical and commercial update on its Adenolysin gene therapy asset for head and neck cancer as its seeks global partners NEW YORK, NEW YORK, USA, June 10, 2021 /EINPresswire.com/ -- Guangzhou Doublle Bio-Product Co …